Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06624202 · ClinicalTrials.gov registry record · NA
COmmunities Aligned to Reduce Concussion and Head Impact Exposure
A NA study of Concussions, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 880
- Enrollment target
- 1
- Study location
NCT06624202: Recruiting NA study of Concussions, sponsored by Wake Forest University Health Sciences.
NCT06624202 is a NA study of Concussions that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 880 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06624202, a NA study of Concussions, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 880 participants
- Enrollment target
- 1
- Study location
Study Summary
Head impacts in collision sports such as football are a public health concern, as repetitive head impacts, even if a concussion is not suspected, have negative effects on brain health. This study has partnered with a community stakeholder group to create a safety program for youth football named "COmmunities Aligned to reduce Concussion and Head impact exposure (COACH)", which seeks to improve knowledge and skills of youth coaches in effective and safe practice planning and to change attitudes and beliefs to prevent head impacts and promote safety. To continue advancing COACH as an approach to prevent head injuries in youth football, this R01 Research Project Grant will determine the ability of youth football organizations to adopt COACH and test if COACH is effective in reducing head impacts, concussion, and negative effects of brain health while monitoring how the program is implemented.
Primary Outcome
Total number of head impacts measured during the season in practices - 0-500 impacts
Conditions Studied
Interventions
- BEHAVIORAL COmmunities Aligned to reduce Concussion and Head impact exposure (COACH) Intervention
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 880 participants |
| Start Date | 2025-05-10 |
| Est. Completion | 2029-12 |
| Phase | NA |
What NCT06624202 shows while recruiting
NCT06624202 is an interventional study that assigns participants to a tested intervention. The registered 880 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower).
The record links to 1 condition, with Concussions appearing as the primary indexed condition, and to 1 intervention - of which COmmunities Aligned to reduce Concussion and Head impact exposure (COACH) Intervention is the first listed.
NCT06624202 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06624202 about?
NCT06624202 is a clinical study titled "COmmunities Aligned to Reduce Concussion and Head Impact Exposure". Head impacts in collision sports such as football are a public health concern, as repetitive head impacts, even if a concussion is not suspected, have negative effects on brain health. This study has partnered with a community stakeholder group to create a safety program for youth football named "CO...
What is the current status of trial NCT06624202?
This trial is currently recruiting. It is a NA study. The enrollment target is 880 participants. The study started on 2025-05-10. Estimated completion is 2029-12.
What conditions does trial NCT06624202 study?
This clinical trial studies the following conditions: Concussions.
What interventions are being tested in trial NCT06624202?
The interventions under investigation include: COmmunities Aligned to reduce Concussion and Head impact exposure (COACH) Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06624202?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06624202 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Concussions
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06624202's enrollment target sits among peer trials
880 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- NCT05454280 · 880 participants · Phase 3
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
- NCT05525663 · 880 participants · NA
Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction
- NCT06580314 · 880 participants · Phase 3
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI